300 related articles for article (PubMed ID: 32487574)
1. Health-related quality Of Life
Younger E; Jones RL; Desar IME; Peckitt C; van der Graaf WTA; Husson O
BMJ Open; 2020 Jun; 10(6):e035171. PubMed ID: 32487574
[TBL] [Abstract][Full Text] [Related]
2.
Soomers V; Desar IM; van de Poll-Franse LV; Husson O; van der Graaf WT
BMJ Open; 2020 Oct; 10(10):e039309. PubMed ID: 33109665
[TBL] [Abstract][Full Text] [Related]
3. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
Gough N; Koffman J; Ross JR; Riley J; Judson I
PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.
Younger E; Litière S; Le Cesne A; Mir O; Gelderblom H; Italiano A; Marreaud S; Jones RL; Gronchi A; van der Graaf WTA
Oncologist; 2018 Oct; 23(10):1250-1259. PubMed ID: 29650688
[TBL] [Abstract][Full Text] [Related]
5. Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study.
Younger E; Jones RL; den Hollander D; Soomers VLMN; Desar IME; Benson C; Young RJ; Oosten AW; de Haan JJ; Miah A; Zaidi S; Gelderblom H; Steeghs N; Husson O; van der Graaf WTA
ESMO Open; 2021 Oct; 6(5):100258. PubMed ID: 34509803
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Coens C; van der Graaf WT; Blay JY; Chawla SP; Judson I; Sanfilippo R; Manson SC; Hodge RA; Marreaud S; Prins JB; Lugowska I; Litière S; Bottomley A
Cancer; 2015 Sep; 121(17):2933-41. PubMed ID: 26033286
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the HuCare Quality Improvement Strategy on health-related quality of life in patients with cancer: study protocol of a stepped-wedge cluster randomised controlled trial (HuCare2 study).
Caminiti C; Iezzi E; Passalacqua R
BMJ Open; 2017 Oct; 7(10):e016347. PubMed ID: 28988170
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
10. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
[TBL] [Abstract][Full Text] [Related]
11. (Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient's knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study).
Kruiswijk AA; van de Sande MAJ; Haas RL; van den Akker-van Marle EM; Engelhardt EG; Marang-van de Mheen P; van Bodegom-Vos L;
BMJ Open; 2023 Nov; 13(11):e074853. PubMed ID: 37918933
[TBL] [Abstract][Full Text] [Related]
12. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY
Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437
[TBL] [Abstract][Full Text] [Related]
14. A cluster-randomised, controlled proof-of-concept study to explore the feasibility and effect of a patient-directed intervention on quality of life in patients with advanced soft tissue sarcoma.
Schuler M; Richter S; Ehninger G; Bornhäuser M; Hentschel L
BMJ Open; 2017 Jun; 7(6):e014614. PubMed ID: 28667207
[TBL] [Abstract][Full Text] [Related]
15. Establishing anchor-based minimally important differences (MID) with the EORTC quality-of-life measures: a meta-analysis protocol.
Musoro ZJ; Hamel JF; Ediebah DE; Cocks K; King MT; Groenvold M; Sprangers MAG; Brandberg Y; Velikova G; Maringwa J; Flechtner HH; Bottomley A; Coens C;
BMJ Open; 2018 Jan; 8(1):e019117. PubMed ID: 29326191
[TBL] [Abstract][Full Text] [Related]
16. Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study.
Eichler M; Hentschel L; Singer S; Hornemann B; Richter S; Hofbauer C; Hohenberger P; Kasper B; Andreou D; Pink D; Jakob J; Grützmann R; Fung S; Wardelmann E; Arndt K; Hermes-Moll K; Schoffer O; Fried M; Jambor HK; Weitz J; Schaser KD; Bornhäuser M; Schmitt J; Schuler MK
Front Endocrinol (Lausanne); 2023; 14():1166838. PubMed ID: 37711899
[TBL] [Abstract][Full Text] [Related]
17. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
18. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
[TBL] [Abstract][Full Text] [Related]
19. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
[TBL] [Abstract][Full Text] [Related]
20. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
